Back to Search
Start Over
Treatment of Insertional Achilles Tendinosis With Polyurethane Urea-Based Matrix Augmentation.
- Source :
-
Foot & ankle specialist [Foot Ankle Spec] 2023 Aug; Vol. 16 (4), pp. 392-398. Date of Electronic Publication: 2022 Sep 30. - Publication Year :
- 2023
-
Abstract
- Introduction: Surgical treatment for insertional Achilles tendinosis (IAT) sometimes requires tendon repair augmentation. The purpose of this study is to evaluate the efficacy of polycaprolactone-based polyurethane urea (PUUR) matrix augmentation in the treatment of IAT.<br />Methods: A retrospective review was performed in surgically treated IAT. Repairs were augmented with a PUUR matrix. Factors evaluated included date of full weightbearing, patient satisfaction, Visual Analog Scale (VAS) pain score, strength, and ankle motion. The Wilcoxon signed-rank test was used to compare baseline and final follow-up VAS scores.<br />Results: A total of 18 cases were included in the study. The mean patient age was 54.61 ± 8.25 (40-75) years with a mean follow-up of 163.61 ± 57.81 (92-314) days. Patient satisfaction was obtained on 15 of 18 patients, with 14 patients satisfied with their outcome. Mean VAS for pain significantly decreased from 6.19 ± 1.97 (2.5-9) to 0.83 ± 1.54 (0-5) postoperatively, which was statistically significant (P < .01).<br />Conclusion: Achilles tendon augmentation with the PUUR matrix is a viable option in the treatment of IAT. Its use in this condition has minimal morbidity and can be an alternative to other forms of augmentation.<br />Levels of Evidence: Level IV: Retrospective case series.
Details
- Language :
- English
- ISSN :
- 1938-7636
- Volume :
- 16
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Foot & ankle specialist
- Publication Type :
- Academic Journal
- Accession number :
- 36181272
- Full Text :
- https://doi.org/10.1177/19386400221125362